Towards a unified framework for single‐cell ‐omics‐based disease prediction through AI
Clinical and Translational Medicine · 2025
DOI: 10.1002/ctm2.70290 ↗Kurz gefasst
Editorial in der Zeitschrift Clinical and Translational Medicine, 2025. Verfasst von Matteo Barberis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Systems Biology, School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK. Hauptthemen laut MEDLINE: Single-Cell Analysis, Artificial Intelligence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Systems Biology Grant of the University of Surrey to Matteo Barberis, Studentship of the Faculty of Health and Medical Sciences of the University of Surrey to Matteo Barberis.
Abstract (Originalsprache)
Single‐cell omics has emerged as a powerful tool for elucidating cellular heterogeneity in health and disease. Parallel advances in artificial intelligence (AI), particularly in pattern recognition, feature extraction and predictive modelling, now offer unprecedented opportunities to translate these insights into clinical applications. Here, we propose single‐cell ‐omics‐based Disease Predictor through AI (scDisPreAI), a unified framework that leverages AI to integrate single‐cell ‐omics data, enabling robust disease and disease‐stage prediction, alongside biomarker discovery. The foundation of scDisPreAI lies in assembling a large, standardised database spanning diverse diseases and multiple disease stages. Rigorous data preprocessing, including normalisation and batch effect correction, ensures that biological rather than technical variation drives downstream models. Machine learning pipelines or deep learning architectures can then be trained in a multi‐task fashion, classifying both disease identity and disease stage. Crucially, interpretability techniques such as SHapley Additive exPlanations (SHAP) values or attention weights pinpoint the genes most influential for these predictions, highlighting biomarkers that may be shared across diseases or disease stages. By consolidating predictive modelling with interpretable biomarker identification, scDisPreAI may be deployed as a clinical decision assistant, flagging potential therapeutic targets for drug repurposing and guiding tailored treatments. In this editorial, we propose the technical and methodological roadmap for scDisPreAI and emphasises future directions, including the incorporation of multi‐omics, standardised protocols and prospective clinical validation, to fully harness the transformative potential of single‐cell AI in precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Molecular Systems Biology, School of Biosciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
- Centre for Mathematical and Computational Biology, CMCB, University of Surrey, Guildford, UK.
ORCID-Profile: Matteo Barberis, Jinkun Xie
Förderung
- Systems Biology Grant of the University of Surrey to Matteo Barberis
- Studentship of the Faculty of Health and Medical Sciences of the University of Surrey to Matteo Barberis
Zitieren
APA
Barberis, M., & Xie, J. (2025). Towards a unified framework for single‐cell ‐omics‐based disease prediction through AI. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.70290
Vancouver
Barberis M, Xie J. Towards a unified framework for single‐cell ‐omics‐based disease prediction through AI. Clinical and Translational Medicine. 2025. doi:10.1002/ctm2.70290
BibTeX
@article{Barberis2025,
author = {Barberis, Matteo and Xie, Jinkun},
title = {Towards a unified framework for single‐cell ‐omics‐based disease prediction through AI},
journal = {Clinical and Translational Medicine},
year = {2025},
doi = {10.1002/ctm2.70290}
}
EUVIMED